Ledger.Open graph →
SEC Form D · filed February 12, 2018

INNOVATE BIOPHARMACEUTICALS, INC

Offering
$92.8M
Sold
$92.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Raleigh, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Kerry Faix · West Chester, PADirectorSanjay Anand · Los Angeles, CAExec · DirectorRomas Matiukas · SAN FRANCISCO, CAExec · DirectorJeong Min Lim · San Francisco, CADirectorTodd R. Tarbert · BELLEVUE, WADirectorSandeep Laumas · Raleigh, NCExec · DirectorAnna Kazanchyan · Raleigh, NCDirectorRoy Proujansky · Raleigh, NCDirectorChristopher Prior · Raleigh, NCExec · DirectorJay Madan · Raleigh, NCExec · DirectorDr. Melissa K. Rhodes · San Francisco, CADirectorJonas Pilkauskas · SAN FRANCISCO, CADirectorHui Chen · New York, NYExec · DirectorKeith S. Greenfield · Boston, MAExec · DirectorVictor Gajendran · Los Angeles, CAExec · DirectorLorin Johnson · Raleigh, NCDirectorAnna Kazanchyan · Raleigh, NCDirectorChristine Tsai · San Francisco, CADirectorAnthony Maida · Raleigh, NCDirectorSteven Lloyd · West Chester, PAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗